187 related articles for article (PubMed ID: 2461715)
1. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats.
Tasaka K; Kamei C; Nakamura S
Arzneimittelforschung; 1994 Mar; 44(3):327-9. PubMed ID: 7910745
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacological properties of optical isomers and a racemic mixture of epinastine.
Tasaka K; Kamei C; Izushi K; Tsujimoto S; Yoshida T
Arzneimittelforschung; 1991 Mar; 41(3):219-23. PubMed ID: 1714277
[TBL] [Abstract][Full Text] [Related]
4. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
5. Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Misawa M; Kanai Y
Arzneimittelforschung; 1991 Nov; 41(11):1145-9. PubMed ID: 1725697
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of the new H1-antagonist 3-amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride in volunteers.
Adamus WS; Oldigs-Kerber J; Lohmann H
Arzneimittelforschung; 1987 May; 37(5):569-72. PubMed ID: 2887173
[TBL] [Abstract][Full Text] [Related]
7. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
[TBL] [Abstract][Full Text] [Related]
8. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (I). Elucidation of the mechanism for histamine release inhibition.
Kamei C; Akagi M; Mio M; Kitazumi K; Izushi K; Masaki S; Tasaka K
Immunopharmacol Immunotoxicol; 1992; 14(1-2):191-205. PubMed ID: 1375955
[TBL] [Abstract][Full Text] [Related]
9. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
Schilling JC; Adamus WS; Kuthan H
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of astemizole (Hismanal) a non-sedating H1 antihistaminic].
Niemegeers CJ
Z Hautkr; 1985; 60 Suppl 1():14-22. PubMed ID: 2581383
[TBL] [Abstract][Full Text] [Related]
11. Terfenadine, the first non-sedating antihistamine.
Woodward JK; Munro NL
Arzneimittelforschung; 1982; 32(9a):1154-6. PubMed ID: 6129860
[TBL] [Abstract][Full Text] [Related]
12. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
Rose C; Quach TT; Llorens C; Schwartz JC
Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
Laduron PM; Janssen PF; Gommeren W; Leysen JE
Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
Mita H; Shida T
Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
[TBL] [Abstract][Full Text] [Related]
15. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
Wiech NL; Martin JS
Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
[TBL] [Abstract][Full Text] [Related]
16. New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine.
Walther G; Daniel H; Bechtel WD; Brandt K
Arzneimittelforschung; 1990 Apr; 40(4):440-6. PubMed ID: 1972625
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of granulocytes in the lung and skin of guinea pigs. Inhibition by the anti-H1 antiallergic agent epinastine.
Fügner A; Meissner C
Arzneimittelforschung; 1994 Dec; 44(12):1338-42. PubMed ID: 7848354
[TBL] [Abstract][Full Text] [Related]
19. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
